Profound Medical Corp PROF

Primary Symbol: T.PRN

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > Price Decline

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Mar 30, 2021 3:48pm

248 Views

Post# 32907773

RE:Price Decline

retiredcf wrote: For anyone wondering about the significant decline in the SP this week, there was no company news and as you know, Raymond James reaffirmed their $43 target. The only thing I can find is that in their earnings release, GUD indicated that they had sold 111K of PRN in the last quarter. GLTA

Ya - just seems like a normal pull-back (as we've seen a few times before.
We have new locations (10 in the USA now).

GUD just reiterated the sale of the shares but they announced it a few quarters back - so that would have mattered more a while back than it does during the yearend summary.

All good !

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December